These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 3379136)

  • 1. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1989 Oct; 69(4):745-52. PubMed ID: 2778033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.
    Clemmons DR; Snyder DK; Williams R; Underwood LE
    J Clin Endocrinol Metab; 1987 May; 64(5):878-83. PubMed ID: 3558728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent lipolytic effect of exogenous growth hormone during caloric restriction.
    Snyder DK; Underwood LE; Clemmons DR
    Am J Med; 1995 Feb; 98(2):129-34. PubMed ID: 7847429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
    Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
    Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent.
    Snyder DK; Underwood LE; Clemmons DR
    Am J Clin Nutr; 1990 Sep; 52(3):431-7. PubMed ID: 2203249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
    Clemmons DR; Smith-Banks A; Underwood LE
    J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
    Murphy MG; Plunkett LM; Gertz BJ; He W; Wittreich J; Polvino WM; Clemmons DR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):320-5. PubMed ID: 9467534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary restriction and repeated growth hormone-releasing factor injections on growth hormone response to growth hormone-releasing factor in obese subjects.
    Csizmadi I; Brazeau P; Serri O
    Metabolism; 1989 Oct; 38(10):1016-21. PubMed ID: 2507875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone.
    Ellis KJ; Lee PD; Pivarnik JM; Bukar JG; Gesundheit N
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3033-8. PubMed ID: 8768870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women.
    Thompson JL; Butterfield GE; Gylfadottir UK; Yesavage J; Marcus R; Hintz RL; Pearman A; Hoffman AR
    J Clin Endocrinol Metab; 1998 May; 83(5):1477-84. PubMed ID: 9589642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.
    Rasmussen MH; Juul A; Kjems LL; Skakkebaek NE; Hilsted J
    J Clin Endocrinol Metab; 1995 Mar; 80(3):796-801. PubMed ID: 7533771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I.
    Clark RG; Mortensen DL; Carlsson LM; Carlsson B; Carmignac D; Robinson IC
    Endocrinology; 1996 May; 137(5):1904-12. PubMed ID: 8612530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
    Young SC; Underwood LE; Celniker A; Clemmons DR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
    Kupfer SR; Underwood LE; Baxter RC; Clemmons DR
    J Clin Invest; 1993 Feb; 91(2):391-6. PubMed ID: 7679407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.